skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Recombinant MAGE-3.1 Antigen (Code C38724)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Recombinant MAGE-3.1 Antigen

Definition: A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma. (NCI04)

Display Name: Recombinant MAGE-3.1 Antigen

Label: Recombinant MAGE-3.1 Antigen

NCI Thesaurus Code: C38724 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1510427  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Recombinant MAGE-3.1 Antigen

External Source Codes: 
PDQ Closed Trial Search ID 42271
PDQ Open Trial Search ID 42271 (check for NCI PDQ open clinical trial info)
UMLS CUI C1510427

Other Properties:
     Name Value (qualifiers indented underneath)
code C38724
Contributing_Source CTRP
Legacy_Concept_Name Recombinant_MAGE-3-1_Antigen
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Immunologic Factor

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom